Findings from McGill University Has Provided New Data on Ovarian Hyperstimulation Syndrome [Gonadotropin Releasing Hormone (Gnrh) Antagonist Administration To Decrease the Risk of Ovarian Hyperstimulation Syndrome In Gnrh Agonist Cycles ...]

Source :: Women's Health Weekly. September 15, 2022, 174
Publication Year :: 2022
Abstract: 2022 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Ovarian Diseases and Conditions - Ovarian Hyperstimulation Syndrome. According [...]

Subjects :: Women -- Health aspects
Medical research
Medicine, Experimental
Glycoproteins -- Research
Chorionic gonadotropin -- Research
Cabergoline -- Research
Hormones -- Research
Ganirelix -- Research
Health
Women's issues/gender studies
McGill University

Tools